Cerity Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$166K Buy
+19,538
New +$130K ﹤0.01% 3101
2025
Q2
– Sell
-25,123
Closed -$200K – 2758
2025
Q1
$200K Buy
25,123
+13,642
+119% +$138K ﹤0.01% 2219
2024
Q4
$105K Sell
11,481
-7,422
-39% -$71.7K ﹤0.01% 2325
2024
Q3
$174K Buy
+18,903
New +$156K ﹤0.01% 2350
2022
Q2
– Sell
-34,913
Closed -$2.52M – 1241
2022
Q1
$2.52M Sell
34,913
-7,216
-17% -$520K 0.04% 291
2021
Q4
$3.87M Sell
42,129
-1,704
-4% -$204K 0.06% 232
2021
Q3
$5.56M Sell
43,833
-6,064
-12% -$883K 0.12% 148
2021
Q2
$8.3M Sell
49,897
-21,997
-31% -$3.56M 0.18% 110
2021
Q1
$13.1M Buy
71,894
+68,133
+1,812% +$15.8M 0.31% 69
2020
Q4
$752K Buy
3,761
+426
+13% +$86.6K 0.02% 344
2020
Q3
$731K Buy
+3,335
New +$706K 0.03% 276

Other funds holding TDOC

Cerity Partners's TDOC Position: Q2 2026 in Review

Cerity Partners opened a new position in Teladoc Health (TDOC) in Q2 2026: 19,538 shares worth $166K. The stake represents ﹤0.01% of the portfolio and ranks #3101 among its holdings. This is a return to the name: Cerity Partners previously reported a position in TDOC as recently as Q1 2025.

Cerity Partners first reported a position in TDOC in Q3 2020 and has held it in 11 quarters since. The position peaked at $13.1M in Q1 2021. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Cerity Partners held 19,538 shares of Teladoc Health worth $166K as of Q2 2026.
  • Teladoc Health was a new Cerity Partners position in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #3101 holding.
  • Cerity Partners first reported a position in Teladoc Health in Q3 2020 and has held it in 11 quarters since.
  • Cerity Partners's Teladoc Health position peaked at $13.1M in Q1 2021.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.